Products & Portfolio (6)
4 discontinued products not shown
ACETADOTE
acetylcysteine
Peak
INTRAVENOUS · INJECTABLE
Reduction Activity
lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in adultsgreater with acute ingestionfrom repeated supratherapeutic ingestion (RSI) ()
2004
0
CALDOLOR
ibuprofen
Peak
SMINTRAVENOUS · SOLUTION
Cyclooxygenase Inhibitors
older for the: Management of mild to moderate painthe management of moderate to severe pain
2009
0
LACTULOSE
lactulose
Post-LOE
ORAL · FOR SOLUTION
Osmotic Activity
1997
30
SANCUSO
granisetron
LOE Approaching
TRANSDERMAL · FILM, EXTENDED RELEASE
Serotonin 3 Receptor Antagonists
2008
30
VAPRISOL
conivaptan hydrochloride
LOE Approaching
INJECTION · INJECTABLE
2007
30
VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
conivaptan hydrochloride
LOE Approaching
INTRAVENOUS · INJECTABLE
2005
30
Open Jobs (0)
No open positions listed yet.
Interview Prep Quick Facts
Portfolio: 10 approved products
Top TAs: Gastroenterology, Hematology, Musculoskeletal
H-1B (2023): 1 approval
Portfolio Health
Pre-Launch1 (10%)
Peak2 (20%)
LOE Approaching6 (60%)
Post-LOE1 (10%)
10 total products
Therapeutic Area Focus
Marketed
Pipeline
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub